About Clear Labs
Clear Labs is a company based in Menlo Park (United States) founded in 2014 by Sasan Amini. Clear Labs has raised $171.09 million across 9 funding rounds from investors including Tencent, Khosla Ventures and T. Rowe Price. Clear Labs offers products and services including Clear Dx™ and Clear Safety™. Clear Labs operates in a competitive market with competitors including Adaptive Biotechnologies, Moderna, Generate Biomedicines, Prenetics and HOOKIPA Pharma, among others.
- Headquarter Menlo Park, United States
- Founders Sasan Amini
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clear Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$171.09 M (USD)
in 9 rounds
-
Latest Funding Round
$30 M (USD), Series D
Dec 12, 2024
-
Investors
Tencent
& 15 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clear Labs
Clear Labs offers a comprehensive portfolio of products and services, including Clear Dx™ and Clear Safety™.
Platform for whole genome sequencing of infectious pathogens
Sequencing for Listeria and Salmonella detection in food
People of Clear Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Clear Labs
Clear Labs has successfully raised a total of $171.09M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $30 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clear Labs
Clear Labs has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Khosla Ventures and T. Rowe Price.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in technology startups are made by Felicis Ventures.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Early-stage investments in healthcare sectors are targeted by HBM Genomics.
|
Locked | Locked | Locked |
Investor details for Clear Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clear Labs
Investment portfolio details for Clear Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clear Labs
Detailed financials for Clear Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clear Labs Comparisons
Peer comparison for Clear Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clear Labs
Clear Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adaptive Biotechnologies, Moderna, Generate Biomedicines, Prenetics and HOOKIPA Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
Detailed competitors of Clear Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clear Labs
Complete news archive for Clear Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clear Labs
Clear Labs was founded in 2014.
Clear Labs is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Sasan Amini is the current CEO of Clear Labs. They have also founded this company.
Clear Labs is a funded company, having raised a total of $171.09M across 9 funding rounds to date.
Clear Labs was founded in 2014 and is located in Menlo Park, United States. Operations center on biotechnology for food safety, where technologies are developed to identify pathogens. The Clear Dx platform is utilized as a next-generation sequencing tool, enabling rapid and high-throughput analysis in clinical and public health laboratories. Complete characterization of SARS-CoV-2 and related threats is supported through this system.
Clear Labs's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Clear Labs offers Clear Dx™ and Clear Safety™.
Clear Labs has 16 investors. Key investors include Tencent, Khosla Ventures, T. Rowe Price, Dentsu, and Plug and Play Tech Center.